7 results
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... Each class of medications ... pharmacotherapy #table ... #medications #diabetes ... #endocrinology
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... EricsMedicalLectures/featured #diabetes ... #medications #table ... #comparison #management ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Type 2 Inpatient Medication ... Guide Classes ... DM2 #Inpatient #Medications ... #pharmacology #comparison ... #table #endocrinology
Intern Pocket Cards - Inpatient Bowel Regimen Guide
Osmotic agents (draws water into bowel, thereby loosening stool
Guide Osmotic agents ... Polyethylene glycol - Nausea ... Guide #Inpatient #medications ... #pharmacology #table ... #comparison
Review of Intranasally Administered Medications for Use in the Emergency Department
Table of agents, uses, dosing, onset
Intranasally Administered Medications ... of agents, uses ... , dosing, onset ... #Comparison #Table ... #Dosing #VisualAbstract
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
Potassium-Binding Agents ... and sodium • Dosing ... #Hyperkalemia #medications ... #pharmacology #table ... #comparison #binders
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... semaglutide, the same medication ... to remain stable ... #semaglutide #Diabetes ... #Pharmacology #Endocrinology